Detalhe da pesquisa
1.
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis.
Eur J Immunol
; 54(1): e2350561, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850588
2.
MicroRNAs targeting TGF-ß signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function.
Eur J Immunol
; : e2350548, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634287
3.
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
Mult Scler
; 27(3): 420-429, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32351164
4.
TGF-ß regulation of encephalitogenic and regulatory T cells in multiple sclerosis.
Eur J Immunol
; 47(3): 446-453, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28102541
5.
Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity.
J Immunol
; 194(9): 4251-64, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795755
6.
MicroRNAs targeting TGFß signalling underlie the regulatory T cell defect in multiple sclerosis.
Brain
; 139(Pt 6): 1747-61, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27190026
7.
Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.
J Neuroinflammation
; 13(1): 302, 2016 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27912762
8.
Analysis of TGF-ß1 and TGF-ß3 as regulators of encephalitogenic Th17 cells: Implications for multiple sclerosis.
Brain Behav Immun
; 46: 44-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25499467
9.
Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated Peptide and dexamethasone in acetalated dextran microparticles.
Mol Pharm
; 11(3): 828-35, 2014 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24433027
10.
miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.
J Immunol
; 189(4): 1567-76, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22772450
11.
Dysregulated autotaxin expression by T cells in multiple sclerosis.
J Neuroimmunol
; 387: 578282, 2024 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183947
12.
Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor κB (NF-κB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling.
J Biol Chem
; 287(33): 28017-26, 2012 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22733812
13.
Glatiramer acetate treatment of multiple sclerosis: an immunological perspective.
J Immunol
; 186(4): 1887-90, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21289312
14.
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference Proceedings.
Neurol Neuroimmunol Neuroinflamm
; 10(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270950
15.
Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?
Biochim Biophys Acta
; 1812(2): 246-51, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20600875
16.
K+ channel alterations in the progression of experimental autoimmune encephalomyelitis.
Neurobiol Dis
; 47(2): 280-93, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22560931
17.
TGF-ß signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE.
Eur J Immunol
; 41(10): 2987-96, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21728174
18.
TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10.
J Immunol
; 184(10): 5628-36, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20393141
19.
Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity.
Brain
; 134(Pt 12): 3578-89, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22088562
20.
Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?
Front Neurol
; 13: 796933, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35651353